Tech Company Financing Transactions
Enlitic Funding Round
Enlitic closed a $25 million Series B venture capital round on 11/15/2019. Investors included Thorney Group, Amplify Partners and Capitol Health.
Transaction Overview
Company Name
Announced On
11/15/2019
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series B
Investors
Thorney Group (Lead Investor) (Alex Waislitz)
Proceeds Purpose
Enlitic will use the proceeds for the next phase build-out of its comprehensive AI software platform and to further grow its global footprint with major regional partners in the healthcare industry, paving the way for market deployment in 2020.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
10 Jackson St.
San Francisco, CA 94111
USA
San Francisco, CA 94111
USA
Phone
Undisclosed
Website
Email Address
Overview
A modern machine learning company dedicated to revolutionizing diagnostic healthcare.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Michael Sistenich
Chief Executive Officer
Kevin Lyman
Chief Medical Officer
Anthony Upton
VP - Bus. Development
Benjamin Brzezynski
VP - Bus. Development
Leo Gurvich
VP - Bus. Development
Arvind Saran
VP - Human Resources
Kristen McDonald
VP - R & D
Mark Freudenberg
VP - Regulatory Affairs
Benjamin Covington
VP - Regulatory Affairs
Adam Odeh
Browse more venture capital transactions:
Prev: 11/15/2019: X-37 venture capital transaction
Next: 11/15/2019: DecisionLink venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to document every notable VC transaction. VC investment data records on this site come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs